Skip to main content

Advertisement

Log in

Do physicians tailor their recommendations for breast cancer risk reduction based on patient’s risk?

  • Original Articles
  • Published:
Journal of General Internal Medicine Aims and scope Submit manuscript

Abstract

OBJECTIVE: To investigate how physicians tailor their recommendations for breast cancer prevention and risk reduction.

DESIGN: Cross-sectional, mail survey.

PARTICIPANTS: Random sample of primary care physicians in California (N=822).

MEASUREMENTS AND MAIN RESULTS: Six standardized patient scenarios were used to assess how women’s breast cancer risk factors influence physicians’ recommendations for screening mammography, counseling about lifestyle behaviors, genetic testing, the use of tamoxifen, prophylactic surgery, and referral to a breast specialist. Over 90% of physicians endorsed mammography for all of the scenarios. Similarly, approximately 80% of physicians endorsed counseling about lifestyle factors for all of the scenarios. Five-year risk of developing breast cancer and family history were both strongly associated with each of the 6 recommendations. Importantly, however, physicians were more likely to endorse the discussion of genetic testing, the use of tamoxifen, and prophylactic surgery for women with a family history of breast cancer compared with women at a higher risk of developing breast cancer but without a family history. Obstetrician-gynecologists were more likely to endorse most of these practices compared with internists.

CONCLUSIONS: Mammography and counseling about lifestyle behaviors are widely endorsed by physicians for breast cancer prevention and risk reduction. Whereas physicians are generally able to tailor their recommendations for prevention and risk reduction based on risk, they may perhaps underutilize genetic evaluation and newer therapeutic options for primary prevention for women who are at high risk of developing breast cancer but do not have a family history.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1997. CA Cancer J Clin. 1997;47:5–27.

    PubMed  CAS  Google Scholar 

  2. Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994;266:66–71.

    Article  PubMed  CAS  Google Scholar 

  3. Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 1998;90:1371–88.

    Article  PubMed  CAS  Google Scholar 

  4. Hartmann LC, Schaid DJ, Woods JE, et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med. 1999;340:77–84.

    Article  PubMed  CAS  Google Scholar 

  5. Hartmann LC, Sellers TA, Schaid DJ, et al. Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst. 2001;93:1633–7.

    Article  PubMed  CAS  Google Scholar 

  6. Powles T, Eeles R, Ashley S, et al. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomized chemoprevention trial. Lancet. 1998;352:98–101.

    PubMed  CAS  Google Scholar 

  7. Veronesi U, Maisonneuve P, Costa A, et al. Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomized trial among hysterectomized women. Italian Tamoxifen Prevention Study. Lancet. 1998;352:93–7.

    PubMed  CAS  Google Scholar 

  8. Shapiro S. Periodic screening for breast cancer: the HIP Randomized Controlled Trial. Health Insurance Plan. J Natl CAncer Inst. 1997;22:27–30.

    Google Scholar 

  9. Tabar L, Chen HH, Fagerberg G, Duffy SW, Smith TC. Recent results from the Swedish Two-County Trial. The effects of age, histologic type, and mode of detection on the efficacy of breast cancer screening. J Natl Cancer Inst. 1997;22:43–7.

    Google Scholar 

  10. Fletcher SW. Breast cancer screening among women in their forties: an overview of the issues. J Natl Cancer Inst. 1997;22:5–9.

    Google Scholar 

  11. Kerlikowske K. Efficacy of screening mammography among women aged 40–49 years and 50–69 years. Comparison of relative and absolute benefit. J Natl Cancer Inst. 1997;22:79–86.

    Google Scholar 

  12. Fletcher SW, Elmore JG. Clinical practice. Mammographic screening for breast cancer. N Engl J Med. 2003;348:1672–80.

    Article  PubMed  Google Scholar 

  13. Mezetti M, La Vecchia C, Decarli A, Boyle P, Talamini R, Franceschi S. Population attributable risk for breast cancer: diet, nutrition and physical exercise. J Natl Cancer Inst. 1998;90:389–93.

    Article  Google Scholar 

  14. Gammon MD, Schoenberg JB, Britton JA, et al. Recreational physical activity and breast cancer risk among women under age 45 years. Am J Epidemiol. 1998;147:273–80.

    PubMed  CAS  Google Scholar 

  15. Huang Z, Hankinson SE, Colditz GA, et al. Dual effects of weight and weight gain on breast cancer risk. JAMA. 1997;278:1407–11.

    Article  PubMed  CAS  Google Scholar 

  16. Smith-Warner S, Spiegelman D, Yaun S-S, et al. Alcohol and breast cancer in women. A pooled analysis of cohort studies. JAMA. 1998;279:535–9.

    Article  PubMed  CAS  Google Scholar 

  17. Kallioniemi A. Molecular signatures of breast cancer—predicting the future. N Engl J Med. 2002;347:2067–8.

    Article  PubMed  Google Scholar 

  18. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81:1879–86.

    Article  PubMed  CAS  Google Scholar 

  19. Lurie N, Margolis KL, Mink PJ, Slater JS. Why do patients of female physicians have higher rate of breast and cervical cancer screening? J Gen Intern Med. 1997;12:34–43.

    Article  PubMed  CAS  Google Scholar 

  20. Herman CJ, Lengerich EJ, Stood G. Variation in recommendations for breast and cervical cancer screening among primary care physicians in North Carolina. South Med J. 1996;89:583–90.

    PubMed  CAS  Google Scholar 

  21. Howe HL, Katterhagen JG. Effects of physician outreach programs on rural-urban differences in breast cancer management. J Rural Health. 1997;13:109–17.

    Article  PubMed  CAS  Google Scholar 

  22. Nattinger AB, Gottlieb MS, Veum J, Yahnke D, Goodwin JS. Geographic variation in the use of breast-conserving treatment for breast cancer. N Engl J Med. 1992;326:1102–7.

    Article  PubMed  CAS  Google Scholar 

  23. Ernster VL, Barclay J, Kerlikowske K, Grady D, Henderson C. Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA. 1996;275:913–8.

    Article  PubMed  CAS  Google Scholar 

  24. Morrow M, Strom EA, Bassett LW, et al. Standard for the management of ductal carcinoma in situ of the breast (DCIS). CA Cancer J Clin. 2002;52:256–76.

    PubMed  Google Scholar 

  25. Kerlikowske K, Molinaro A, Cha I, et al. Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy. J Natl Cancer Inst. 2003;95:1692–702.

    PubMed  Google Scholar 

  26. Lipsitz SR, Fitzmaurice GM, Orav EJ, Laird NM. Performance of generalized estimating equations in practical situations. Biometrics. 1994;50:270–8.

    Article  PubMed  CAS  Google Scholar 

  27. U.S. Preventive Services Task Force. 2002. Available at: http://www.ahcpr.gov/clinic/uspstfix.htm. Accessed February 27, 2004.

  28. Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL. Efficacy of screening mammography. A meta-analysis. JAMA. 1995;273:149–54.

    Article  PubMed  CAS  Google Scholar 

  29. Willet WC, Browne ML, Bain C. Relative weight and risk of breast cancer among premenopausal women. Am J Epidemiol. 1985;122:731–9.

    Google Scholar 

  30. Hunter DJ, Willett WC. Nutrition and breast cancer. Cancer Causes Control. 1996;7:56–68.

    Article  PubMed  CAS  Google Scholar 

  31. Pathak DR, Whittemore AS. Combined effects of body size, parity and menstrual events on breast cancer incidence in seven countries. Am J Epidemiol. 1992;135:153–67.

    PubMed  CAS  Google Scholar 

  32. Hankinson SE, Willet WC, Manson JE. Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J Natl Cancer Inst. 1995;87:1297–302.

    Article  PubMed  CAS  Google Scholar 

  33. Sakorafas GH. The management of women at high risk for the development of breast cancer: risk estimation and preventative strategies. Cancer Treat Rev. 2003;29:79–89.

    Article  PubMed  Google Scholar 

  34. Ernster VL, Ballard-Barbash R, Barlow WE, et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst. 2002;94:1546–54.

    PubMed  Google Scholar 

  35. Ernster VL, Barclay J, Kerlikowske K, Wilkie H, Ballard-Barbash R. Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program. Arch Intern Med. 2000;160:953–8.

    Article  PubMed  CAS  Google Scholar 

  36. Wideroff L, Freedman AN, Olson L, et al. Physician use of genetic testing for cancer susceptibility: results of a national survey. Cancer Epidemiol Biomarkers Prev. 2003;12:295–303.

    PubMed  Google Scholar 

  37. Cuzick J, Forbes J, Edwards R, et al. First results from the International Breast Cancer Intervention Study (IBIS-I): a randomized prevention trial. Lancet. 2002;360:817–24.

    Article  PubMed  CAS  Google Scholar 

  38. Freedman AN, Graubard BI, Rao SR, McCaskill-Stevens W, Ballard-Barbash R, Gail MH. Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention. J Natl Cancer Inst. 2003;95:526–32.

    Article  PubMed  CAS  Google Scholar 

  39. Schrag D, Kuntz KM, Garber JE, Weeks JC. Decision analysis—effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations. N Engl J Med. 1997;336:1465–71.

    Article  PubMed  CAS  Google Scholar 

  40. Kinney AY, Richards C, Vernon SW, Vogel VG. The effect of physician recommendation on enrollment in the breast cancer chemoprevention trial. Prev Med. 1998;27(5 Part 1):713–9.

    Article  PubMed  CAS  Google Scholar 

  41. Fox SA, Siu AL, Stein JA. The importance of physician communication on breast cancer screening of older women. Arch Intern Med. 1994;154:2058–68.

    Article  PubMed  CAS  Google Scholar 

  42. Armstrong K, Stopfer J, Calzone K, Fitzgerald G, Coyne J, Weber B. What does my doctor think? Preferences for knowing the doctor’s opinion among women considering clinical testing for BRCA1/2 mutations. Genet Test. 2002;6:115–8.

    Article  PubMed  Google Scholar 

  43. Yarnall KS, Pollak KI, Ostbye T, Krause KM, Michener JL. Primary care: is there enough time for prevention? Am J Public Health. 2003;93:635–41.

    PubMed  Google Scholar 

  44. Houn F, Helzlsouer KJ, Friedmna NB, Stefanek ME. The practice of prophylactic mastectomy. A survey of Maryland surgeons. Am J Public Health. 1995;85:801–5.

    Article  PubMed  CAS  Google Scholar 

  45. Frank E, Rock J, Sara D. Characteristics of female obstetrician-gynecologists in the United States. Obstet Gynecol. 1999;94(5 Part 1):659–65.

    Article  PubMed  CAS  Google Scholar 

  46. Gandhi TK, Francis EC, Puopolo AL, Burstin HR, Haas JS, Brennan TA. Inconsistent report cards: assessing the comparability of various measures of the quality of ambulatory care. Med Care. 2002;40:155–65.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jennifer S. Haas MD, MSPH.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Haas, J.S., Kaplan, C.P., Gregorich, S.E. et al. Do physicians tailor their recommendations for breast cancer risk reduction based on patient’s risk?. J GEN INTERN MED 19, 302–309 (2004). https://doi.org/10.1111/j.1525-1497.2004.30280.x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1111/j.1525-1497.2004.30280.x

Key words

Navigation